Cancer

Media Release: New anti-cancer drugs put cancers to sleep…permanently

A member of the CRC program, St Vincent’s Institute and Bio21 Institute, University of Melbourne’s Professor Michael Parker and his team contributed to the structural biology of the target proteins KAT6A and KAT6B, as well as the corresponding selective inhibitors.

On the ‘breadcrumb trail’ of aggressive lung cancer

Bio21's Dr David De Souza and Professor Malcolm McConville working together with Dr Kate Sutherland and Dr Sarah Best from the Walter and Eliza Hall Institute, have confirmed the mutations responsible for lung adenocarcinomas and identified unique diagnostic signatures.

Associate Professor Robin Anderson presents 'BMP4 inhibits metastasis through multiple mechanisms'

Wednesday, 4 November, 2015 - 12:00 to 13:00

Biochemistry and Molecular Biology Seminar Series every Wednesday in the Bio21 auditorium, 12-1pm.

Subscribe to RSS - Cancer